Bayern Kapital

Hema.to specializes in AI-powered blood cancer detection software. It automates the analysis of flow cytometry data, enhancing lab efficiency and accuracy.

Caire intends to revolutionize health monitoring by utilizing AI to extract vital signs and health diagnoses from facial recordings.

Ryver specializes in developing software solutions for data collaboration and sharing while prioritizing privacy. The company's platform enables clients to generate synthetic data from original datasets efficiently, particularly in the medical field, where it facilitates the rapid access to radiology cases. By automating the evaluation of privacy and utility of synthetic data, Ryver eliminates the need for manual compliance processes, significantly reducing the time and cost associated with data acquisition. Their technology seamlessly integrates into various data warehouses, cloud environments, and IT infrastructures, thereby providing detailed compliance and usage information. This innovative approach supports medical AI teams in creating high-quality radiology images with annotations, enhancing both speed and effectiveness in medical data utilization.

deepeye is a company that develops an AI-powered precision medicine platform for retinal diseases. The platform enables ophthalmologists to tailor therapies for conditions such as age-related macular degeneration and other retinal disorders by analyzing therapy data and providing second opinions on treatment needs and scheduling. It serves clinicians, pharmaceutical developers, payors, and provider associations to improve therapy outcomes and prevent vision loss.

InContAlert is a deep tech company innovating in the field of incontinence management. It develops an mHealth device that monitors urinary bladder filling levels using advanced algorithms. The device sends alerts to users and caregivers when predefined thresholds are reached, minimizing risks associated with uncontrolled urine loss or bladder distension.

EGYM is a global fitness technology company that empowers gym operators to deliver intelligent workout solutions through its connected gym equipment and software. It aims to enhance members' fitness journeys by providing data-based guidance, fostering physical and mental wellness.

Mbiomics is a biotechnology company focused on transforming microbiome research, diagnostics, and therapeutics. The firm operates a high-throughput, low-cost platform designed for dynamic and real-time analysis and quantification of the human gut microbiome. This technology enables precise diagnostics and targeted therapies, aiming to enhance patients' lives through innovative approaches to health management.

AlfaDocs is a practice management system tailored for healthcare professionals, particularly in the fields of dentistry and general medical practice. The company offers a cloud-based platform that facilitates the connection between doctors and patients, enabling streamlined communication and efficient management of medical practices. Its software provides essential tools for digitalization, centralization, automation, and integration, allowing healthcare providers to maintain patient records, generate reports, and manage radiographs. Additionally, AlfaDocs includes billing and analysis services, simplifying clinic and outpatient operations and enhancing the overall efficiency of healthcare delivery.

Ebenbuild is a technology company that specializes in developing and commercializing advanced health tech solutions focused on respiratory diseases. Building on two decades of research from TU Munich, the company employs lung simulation models to create a versatile platform with applications in both drug development and healthcare. One of its key innovations is a digital trials application that enhances drug delivery predictions, thereby accelerating the drug development process for Biotech, Pharma, and MedTech companies. This application allows for the optimization of delivery parameters before clinical trials, thus increasing success rates. Additionally, Ebenbuild's healthcare application integrates with hospital IT systems to provide actionable intelligence at the patient's bedside. It focuses on personalizing mechanical ventilation for patients with Acute Respiratory Distress Syndrome, significantly improving their prognosis. By continuously expanding its platform to address various indications, Ebenbuild aims to enhance patient outcomes while supporting medical staff and healthcare systems.

Cliniserve develops digital task management and communication software for hospital nurses and patients. Its products include patient communication tools, a point-of-care interface for ward staff, patient care insights dashboard, and digital absence management system. Founded in Munich, Germany in 2017, Cliniserve aims to enhance nursing processes by reducing workload and increasing time spent with patients.

NeoPrediX develops decision support tools and digital health solutions for maternal, neonatal, and perinatal screening to evaluate, optimize, and personalize medical strategies in pediatrics. It translates medical data into intelligent predictions using advanced algorithms to support clinical decisions in neonatal and perinatal care, enabling practitioners to tailor treatments in early life and reduce the risk of long-term complications.

EGYM is a global fitness technology company that empowers gym operators to deliver intelligent workout solutions through its connected gym equipment and software. It aims to enhance members' fitness journeys by providing data-based guidance, fostering physical and mental wellness.

iATROS GmbH is a Munich-based company founded in 2019 that specializes in developing a mobile application and platform aimed at enhancing the care of cardiology patients. The platform connects patients with medical caregivers and offers a range of services, including therapy and medication planning, progress tracking, ECG diagnosis, and the maintenance of blood pressure and sugar databases. It also facilitates consultations with physicians and enables the secure storage of health data. As the prevalence of cardiovascular diseases increases, iATROS aims to improve the lives of both chronic and acute patients while addressing the significant healthcare costs associated with these conditions. By leveraging smart health trackers, vital data collection, and advanced AI analytics, the company enhances treatment outcomes and provides patients with 24/7 access to healthcare professionals, ensuring they feel safe in managing their conditions.

iThera Medical develops biomedical imaging technology based on photonic molecular imaging and multispectral optoacoustic tomography (MSOT) for preclinical and clinical applications. The company leverages the photoacoustic effect to visualize and quantify anatomical, functional, and molecular information in vivo, including deep tissue visualization and real-time imaging, enabling non-invasive assessment of tumors and inflammatory diseases. Founded in 2010 as a spin-off from Helmholtz Zentrum München, iThera Medical focuses on advancing MSOT technology for use in preclinical research and clinical trials, supporting researchers and clinicians in obtaining deeper insights into biological processes without invasive procedures.

advanceCOR is a clinical drug development company focused on therapeutics and diagnostics for heart and vascular diseases. Its activities span research, development, and plans for commercialization to enable personalized treatment of cardiovascular conditions. Lead candidates include Revacept, a human Fc fusion protein that prevents local platelet activation at sites of vascular injury; COR-2, a recombinant protein that interferes with foam cell formation and the uptake of cholesterol; and COR-3, a recombinant protein that binds to atherosclerotic plaques and bi-specifically captures circulating progenitor cells to promote plaque healing. The company also develops antibodies and fusion proteins targeting platelet receptors and other components involved in arterial thrombosis and plaque progression, with an emphasis on addressing acute events such as myocardial infarction and stroke.

Lophius Biosciences GmbH is a biotechnology company based in Regensburg, Germany, specializing in the development of innovative immune diagnostic systems aimed at enhancing the diagnosis and management of acute infectious and autoimmune diseases. Founded in 2002, the company focuses on immunology and T-cell diagnostics, offering a range of products including diagnostic kits, elispot kits, antibodies, and related materials. Lophius Biosciences employs proprietary technologies such as T-activation® and Reverse T Cell Technology, which enable efficient stimulation of immune effector cells and allow differentiation between active and memory T cells. This expertise facilitates accurate measurement of cell-mediated immunity, supporting personalized treatment strategies for patients, particularly in transplantation and infectious disease contexts. Additionally, the company provides custom services in cell-based bioactivity and quality testing for pharmaceutical agents.

numares AG is a German company that specializes in developing and marketing software-based test systems for clinical diagnostics and life science research. Founded in 2004 and headquartered in Regensburg, the company employs nuclear magnetic resonance (NMR) spectroscopy to create diagnostic tests that evaluate metabolomic networks. Its AXINON in vitro diagnostic (IVD) system produces a numeric spectrum that provides valuable insights into patients' disease statuses, assisting physicians in their evaluations. Utilizing magnetic group signaling (MGS) technology, numares focuses on diagnostics in areas such as cardiovascular diseases, nephrology, oncology, and neurology. The company is recognized as a leader in commercial NMR analytics in Europe, offering a comprehensive range of NMR-analytic services that are fast, cost-efficient, and reliable, enabling doctors to interpret complex metabolic patterns from blood and urine samples effectively.

Lophius Biosciences GmbH is a biotechnology company based in Regensburg, Germany, specializing in the development of innovative immune diagnostic systems aimed at enhancing the diagnosis and management of acute infectious and autoimmune diseases. Founded in 2002, the company focuses on immunology and T-cell diagnostics, offering a range of products including diagnostic kits, elispot kits, antibodies, and related materials. Lophius Biosciences employs proprietary technologies such as T-activation® and Reverse T Cell Technology, which enable efficient stimulation of immune effector cells and allow differentiation between active and memory T cells. This expertise facilitates accurate measurement of cell-mediated immunity, supporting personalized treatment strategies for patients, particularly in transplantation and infectious disease contexts. Additionally, the company provides custom services in cell-based bioactivity and quality testing for pharmaceutical agents.

microDimensions develops software solutions for processing, analyzing, and visualizing microscopic image data, primarily in biomedical fields. Its key products include Voloom (for automated 3D reconstruction), Zoom (for fast visualization of whole slide images), and anyslide/slidematch. These tools assist pharmaceutical, biotechnology, and pathology researchers with tasks like cell counting, tumor border computation, scoring, volume measurements, and finding regions in serial sections. microDimensions offers its products through distribution partners.

EGYM is a global fitness technology company that empowers gym operators to deliver intelligent workout solutions through its connected gym equipment and software. It aims to enhance members' fitness journeys by providing data-based guidance, fostering physical and mental wellness.

EGYM is a global fitness technology company that empowers gym operators to deliver intelligent workout solutions through its connected gym equipment and software. It aims to enhance members' fitness journeys by providing data-based guidance, fostering physical and mental wellness.

microDimensions develops software solutions for processing, analyzing, and visualizing microscopic image data, primarily in biomedical fields. Its key products include Voloom (for automated 3D reconstruction), Zoom (for fast visualization of whole slide images), and anyslide/slidematch. These tools assist pharmaceutical, biotechnology, and pathology researchers with tasks like cell counting, tumor border computation, scoring, volume measurements, and finding regions in serial sections. microDimensions offers its products through distribution partners.

Photonics Healthcare GmbH is a medical device company based in Garching, Germany, specializing in the development and commercialization of clinical monitors for cellular oxygen measurement. The company's flagship product, the COMET Monitor, enables healthcare professionals to assess cellular oxygen metabolism, including the availability and consumption of oxygen in tissue cells. This non-invasive device provides critical data at the bedside, allowing doctors to detect hypoxia early, evaluate tissue vitality, and make informed decisions regarding treatment interventions. By accurately measuring mitochondrial oxygen availability and tension, Photonics Healthcare aims to enhance patient care and prevent potential organ failure, thereby improving the overall effectiveness of medical interventions. Additionally, the company offers contract research programs to support further advancements in the field.

Dynamic Biosensors develops biomolecular interaction analysis solutions. Its flagship product is switchSENSE, a label-free system for analyzing molecular interactions using electrically actuated DNA interfaces. The company's products are used in various applications such as protein-protein and DNA analyses.

numares AG is a German company that specializes in developing and marketing software-based test systems for clinical diagnostics and life science research. Founded in 2004 and headquartered in Regensburg, the company employs nuclear magnetic resonance (NMR) spectroscopy to create diagnostic tests that evaluate metabolomic networks. Its AXINON in vitro diagnostic (IVD) system produces a numeric spectrum that provides valuable insights into patients' disease statuses, assisting physicians in their evaluations. Utilizing magnetic group signaling (MGS) technology, numares focuses on diagnostics in areas such as cardiovascular diseases, nephrology, oncology, and neurology. The company is recognized as a leader in commercial NMR analytics in Europe, offering a comprehensive range of NMR-analytic services that are fast, cost-efficient, and reliable, enabling doctors to interpret complex metabolic patterns from blood and urine samples effectively.

numares AG is a German company that specializes in developing and marketing software-based test systems for clinical diagnostics and life science research. Founded in 2004 and headquartered in Regensburg, the company employs nuclear magnetic resonance (NMR) spectroscopy to create diagnostic tests that evaluate metabolomic networks. Its AXINON in vitro diagnostic (IVD) system produces a numeric spectrum that provides valuable insights into patients' disease statuses, assisting physicians in their evaluations. Utilizing magnetic group signaling (MGS) technology, numares focuses on diagnostics in areas such as cardiovascular diseases, nephrology, oncology, and neurology. The company is recognized as a leader in commercial NMR analytics in Europe, offering a comprehensive range of NMR-analytic services that are fast, cost-efficient, and reliable, enabling doctors to interpret complex metabolic patterns from blood and urine samples effectively.

Lophius Biosciences GmbH is a biotechnology company based in Regensburg, Germany, specializing in the development of innovative immune diagnostic systems aimed at enhancing the diagnosis and management of acute infectious and autoimmune diseases. Founded in 2002, the company focuses on immunology and T-cell diagnostics, offering a range of products including diagnostic kits, elispot kits, antibodies, and related materials. Lophius Biosciences employs proprietary technologies such as T-activation® and Reverse T Cell Technology, which enable efficient stimulation of immune effector cells and allow differentiation between active and memory T cells. This expertise facilitates accurate measurement of cell-mediated immunity, supporting personalized treatment strategies for patients, particularly in transplantation and infectious disease contexts. Additionally, the company provides custom services in cell-based bioactivity and quality testing for pharmaceutical agents.

Curefab Technologies is a developer of advanced medical technologies focused on the objective quantitative assessment of diagnostic image data. The company's innovations enhance diagnostic certainty, facilitating early detection of cardiovascular and oncological diseases. Curefab's technologies play a crucial role in stroke prevention, the early diagnosis of vascular conditions, and the monitoring of cancer therapies. Additionally, the company offers computed sonography systems that allow for the comparison and analysis of ultrasound images, thereby providing physicians with relevant diagnostic parameters essential for patient care.

ChromoTek GmbH is a biotechnology company based in Planegg-Martinsried, Germany, founded in 2008. The company specializes in the development of innovative immunologic research tools and detection reagents aimed at enhancing proteomics and cell biology applications. ChromoTek's products are derived from single domain camel antibodies, providing advanced solutions for health institutions and researchers. By offering these unique tools, ChromoTek aims to improve research capabilities and outcomes in various scientific fields worldwide.

Lophius Biosciences GmbH is a biotechnology company based in Regensburg, Germany, specializing in the development of innovative immune diagnostic systems aimed at enhancing the diagnosis and management of acute infectious and autoimmune diseases. Founded in 2002, the company focuses on immunology and T-cell diagnostics, offering a range of products including diagnostic kits, elispot kits, antibodies, and related materials. Lophius Biosciences employs proprietary technologies such as T-activation® and Reverse T Cell Technology, which enable efficient stimulation of immune effector cells and allow differentiation between active and memory T cells. This expertise facilitates accurate measurement of cell-mediated immunity, supporting personalized treatment strategies for patients, particularly in transplantation and infectious disease contexts. Additionally, the company provides custom services in cell-based bioactivity and quality testing for pharmaceutical agents.

numares AG is a German company that specializes in developing and marketing software-based test systems for clinical diagnostics and life science research. Founded in 2004 and headquartered in Regensburg, the company employs nuclear magnetic resonance (NMR) spectroscopy to create diagnostic tests that evaluate metabolomic networks. Its AXINON in vitro diagnostic (IVD) system produces a numeric spectrum that provides valuable insights into patients' disease statuses, assisting physicians in their evaluations. Utilizing magnetic group signaling (MGS) technology, numares focuses on diagnostics in areas such as cardiovascular diseases, nephrology, oncology, and neurology. The company is recognized as a leader in commercial NMR analytics in Europe, offering a comprehensive range of NMR-analytic services that are fast, cost-efficient, and reliable, enabling doctors to interpret complex metabolic patterns from blood and urine samples effectively.

Corimmun is a clinical drug development company based in Martinsried, near Munich, Germany, specializing in innovative therapeutics and diagnostics for heart and vascular diseases. The company is dedicated to addressing unmet medical needs in the field of cardiovascular health. Corimmun's expertise encompasses the entire process of drug development, from initial research through to commercialization. By focusing on novel treatment options, Corimmun aims to improve outcomes for patients suffering from cardiovascular conditions.

numares AG is a German company that specializes in developing and marketing software-based test systems for clinical diagnostics and life science research. Founded in 2004 and headquartered in Regensburg, the company employs nuclear magnetic resonance (NMR) spectroscopy to create diagnostic tests that evaluate metabolomic networks. Its AXINON in vitro diagnostic (IVD) system produces a numeric spectrum that provides valuable insights into patients' disease statuses, assisting physicians in their evaluations. Utilizing magnetic group signaling (MGS) technology, numares focuses on diagnostics in areas such as cardiovascular diseases, nephrology, oncology, and neurology. The company is recognized as a leader in commercial NMR analytics in Europe, offering a comprehensive range of NMR-analytic services that are fast, cost-efficient, and reliable, enabling doctors to interpret complex metabolic patterns from blood and urine samples effectively.

AlfaDocs is a practice management system tailored for healthcare professionals, particularly in the fields of dentistry and general medical practice. The company offers a cloud-based platform that facilitates the connection between doctors and patients, enabling streamlined communication and efficient management of medical practices. Its software provides essential tools for digitalization, centralization, automation, and integration, allowing healthcare providers to maintain patient records, generate reports, and manage radiographs. Additionally, AlfaDocs includes billing and analysis services, simplifying clinic and outpatient operations and enhancing the overall efficiency of healthcare delivery.